Nakata J, Maruyama Y, Ozasa K, Young A, Noma N. Oral Candidiasis Mimicking Mucosal Lesions of Bullous Pemphigoid During Systemic Corticosteroid Therapy: A Case Report. J Clin Exp Dent. 2025;17(9):e1159-62.

doi:10.4317/jced.63038

___

References

1. Venkatalakshmi AP, Kailasam S, Namachivayam N, Gopinath J. Oral bullous pemphigoid - a rarity among vesiculobullous lesions. Journal of IAOMR. 2018;30:432-5. https://doi.org/10.4103/jiaomr.jiaomr_150_18

2. Kumar JV, Kumar SP, Reddy MP. Oral medicine in India: Past, present, and future. J Infect Dis Ther. 2014;2:136.

3. Chen J, Mao X, Zhao W, Zhang B, Chen X, Yu C, Zheng Z, Jin H, Li L. Assessment of the characteristics and associated factors of infectious complications in bullous pemphigoid. Front Immunol. 2020;23:1607. https://doi.org/10.3389/fimmu.2020.01607 PMid:32793235 PMCid:PMC7390841

4. Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med. 2019;10:76. https://doi.org/10.3390/jcm8010076 PMid:30634716 PMCid:PMC6352194

5. Almugairen N, Hospital V, Bedane C, Duvert-Lehembre S, Picard D, Tronquoy AF, et al. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids. J Am Acad Dermatol. 2013;69:583-8. https://doi.org/10.1016/j.jaad.2013.05.016 PMid:23850258

6. Fichel F, Barbe C, Joly P, Bedane C, Vabres P, Truchetet F, et al. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study. JAMA Dermatol. 2014;150:25-33 https://doi.org/10.1001/jamadermatol.2013.5757 PMid:24226428

7. Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol. 2013;31(3):400-12. PMid:20082959